Inactive Instrument

Applied DNA Sciences Inc Share Price OTC Bulletin Board

Equities

US03815U1025

Medical Equipment, Supplies & Distribution

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Applied DNA Sciences Inc
Sales 2024 * 4.5M 347M Sales 2025 * 6.76M 522M Capitalization 4.49M 347M
Net income 2024 * -12M -925M Net income 2025 * -13M -1B EV / Sales 2024 * 1 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.66 x
P/E ratio 2024 *
-0.08 x
P/E ratio 2025 *
-0.46 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.49%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 71 27/09/05
Director of Finance/CFO 47 30/04/13
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 74 16/03/06
Director/Board Member 87 06/10/16
Chief Executive Officer 71 27/09/05
More insiders
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
More about the company